These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20179520)

  • 21. Clinical use of hydroxyethylstarch: colloidal confusion or clarity?
    Lang JD; Chaiwat O
    Crit Care Med; 2007 Dec; 35(12):2864-6. PubMed ID: 18043209
    [No Abstract]   [Full Text] [Related]  

  • 22. [Doubts about HES. The European Medicines Agency withdraws the marketing permit until further notice].
    Svensén C
    Lakartidningen; 2013 Aug 7-20; 110(32-33):1399. PubMed ID: 23980378
    [No Abstract]   [Full Text] [Related]  

  • 23. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hydroxyethylstarches and postoperative renal dysfunction].
    Mion G; Libert N; Cirodde A
    Ann Fr Anesth Reanim; 2010 Jan; 29(1):58; author reply 58-9. PubMed ID: 20071134
    [No Abstract]   [Full Text] [Related]  

  • 25. Modern starches are not safer than old ones.
    Hartog C; Reinhart K
    Anesth Analg; 2009 Oct; 109(4):1346; author reply 1347. PubMed ID: 19762770
    [No Abstract]   [Full Text] [Related]  

  • 26. The next generation of colloids: ready for "prime time"?
    Nussmeier NA; Searles BE
    Anesth Analg; 2009 Dec; 109(6):1715-7. PubMed ID: 19923493
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent developments in European colloid solutions.
    Dieterich HJ
    J Trauma; 2003 May; 54(5 Suppl):S26-30. PubMed ID: 12768098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.
    Shaw AD; Kellum JA
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):497-503. PubMed ID: 23335037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of hydroxyethyl starch in patients with renal insufficiency].
    Dieterich HJ
    Anaesthesist; 1996 Oct; 45(10):995. PubMed ID: 8992915
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration.
    Haskell LP; Tannenberg AM
    N Y State J Med; 1988 Jul; 88(7):387-8. PubMed ID: 2457189
    [No Abstract]   [Full Text] [Related]  

  • 32. The pros and cons of hydroxyethyl starch solutions.
    Vincent JL
    Anesth Analg; 2007 Mar; 104(3):484-6. PubMed ID: 17312191
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hydroxyethyl starch--a new interesting colloidal plasma volume expander. Anaphylactoid reactions (author's transl)].
    Seidemann J
    Zentralbl Chir; 1979; 104(22):1457-64. PubMed ID: 95073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polish hydroxyethyl starch preparation: a clinical study].
    Schier J; Kościelak J; Szczepanik A; Gryszkiewicz A; Lopaciuk S; Konopka L; Rudowski W
    Acta Haematol Pol; 1979; 10(1):51-8. PubMed ID: 86269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hydroxyethylstarch-induced pruritus: an understimated side effect of its application also in ENT diseases].
    Weisshaar E; Iro H; Zenk J
    Laryngorhinootologie; 2009 Sep; 88(9):604-8; quiz 609-11. PubMed ID: 19711242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibres.
    Ständer S; Evers S; Metze D; Schmelz M
    Br J Dermatol; 2005 May; 152(5):1085-6. PubMed ID: 15888187
    [No Abstract]   [Full Text] [Related]  

  • 37. The Scandinavian Critical Care Trials Group: producing important new findings in challenging times.
    Flaatten H; Haney M; Wernerman J
    Acta Anaesthesiol Scand; 2013 Feb; 57(2):138-40. PubMed ID: 23294054
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
    Penner M; Fingerhut D; Tacke A
    Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of acute normovolemic haemodilution with hydroxyethyl starch during intracranial surgery.
    Kiran Prasad KM; Devaragudi TS; Christopher R; Chandramouli BA; Umamaheswara Rao GS
    Neurol India; 2000 Mar; 48(1):63-7. PubMed ID: 10751816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers.
    James MF; Latoo MY; Mythen MG; Mutch M; Michaelis C; Roche AM; Burdett E
    Anaesthesia; 2004 Aug; 59(8):738-42. PubMed ID: 15270962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.